WASHINGTON UNIVERSITY SCHOOL OF MEDICINE, IN COLLABORATION WITH MEDIBEACON™ LLC, Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development - Siouxland News - KMEG 14 and FOX 44

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE, IN COLLABORATION WITH MEDIBEACON™ LLC, Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE MediBeacon, LLC

ST LOUIS, June 4, 2014 /PRNewswire/ -- Washington University School of Medicine in St. Louis announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Phillip I. Tarr MD, director of the Division of Pediatric Gastroenterology, Hepatology and Nutrition at the School of Medicine and St. Louis Children's Hospital, in collaboration with MediBeacon LLC, will pursue an innovative global health and development research project for monitoring human gut permeability.

Grand Challenges Explorations (GCE) funds individuals worldwide to explore ideas that can break the mold in how we solve persistent global health and development challenges. Over 1,700 applications were submitted this year. Dr. Tarr's project is one of about 50 Grand Challenges Explorations Round 12 grants announced today by the Bill & Melinda Gates Foundation. 

To receive funding, Dr. Tarr and other Grand Challenges Explorations Round 12 winners demonstrated in a two-page online application a bold idea in one of five critical global heath and development topic areas that included agriculture development, behavior change and looking into animal and human health. Applications for the next round will be accepted starting in September. 

Dr. Tarr, who is also the Melvin E. Carnahan Professor of Pediatrics and a professor of molecular microbiology at the School of Medicine, said: "Children in low- and middle-income countries frequently have increased gut permeability, which is believed to underlie intestinal dysfunction and poor growth. However, there are many challenges in trying to measure gut permeability with the current tools. I look forward to tackling these challenges by applying novel fluorescence detection technology from MediBeacon, and I am grateful to the Bill & Melinda Gates Foundation Grand Challenges program for the support to do so."

There is growing research connecting abnormal gut permeability to other disorders, such as inflammatory bowel diseases, especially Crohn's disease and Celiac disease. Richard Dorshow, PhD, MediBeacon's co-founder and chief scientific officer, said: "The ability to measure a patient's gut function noninvasively without the need for time-consuming and often impractical fluid collection and analytics would be a large step forward. We are excited about the potential to help patients in less developed countries by increasing our understanding of methods to monitor different gastrointestinal diseases using MediBeacon's technology."

About Grand Challenges Explorations

Grand Challenges Explorations is a US$100 million initiative funded by the Bill & Melinda Gates Foundation. Launched in 2008, over 950 people in more than 55 countries have received Grand Challenges Explorations grants. The grant program is open to anyone from any discipline and from any organization. The initiative uses an agile, accelerated grant-making process with short two-page online applications and no preliminary data required.  Initial grants of US$100,000 are awarded two times a year. Successful projects have the opportunity to receive a follow-on grant of up to US$1 million.

About MediBeacon, LLC:

MediBeacon LLC is focused on providing clinicians with critical information to improve patient care. MediBeacon has completed initial human trials on its noninvasive point-of-care kidney function monitoring system. The company holds 16 US patents, 35 global patents and has 50 pending patent applications. MediBeacon was initially funded by the St Louis Development Corp., St Louis BioGenerator, the Missouri Technology Corp. and the Helix Fund. MediBeacon is housed within the Helix Center Biotech Incubator in St. Louis. Information regarding MediBeacon can be found at www.medibeacon.com.

©2012 PR Newswire. All Rights Reserved.

  • NewsNewsMore>>

  • Rock Valley Woman Killed In Accident

    Rock Valley Woman Killed In Accident

    (INWOOD, IA)  Rock Valley woman killed in a accident over the weekend.More >>
    (INWOOD, IA)  Rock Valley woman killed in an accident over the weekend.
    More >>
  • Spending on Iraq

    Spending on Iraq

    (WASHINGTON, D.C.) Countries around the world are sending humanitarian aid to Iraq in response to violence by Islamic militants. The U.S. has a goal of helping end the violence, and provide significant humanitarian assistance to the people of Iraq.More >>
    (WASHINGTON, D.C.) Countries around the world are sending humanitarian aid to Iraq in response to violence by Islamic militants. The U.S. has a goal of helping end the violence, and provide significant humanitarian assistance to the people of Iraq.More >>
  • Sergeant Bluff Community Rallies Together to Tackle Storm Damage

    Sergeant Bluff Community Rallies Together to Tackle Storm Damage

    (SERGEANT BLUFF, IA) Less than 24 hours after strong winds ripped through Sergeant Bluff, heavy duty machinery, firefighters, and volunteers took over. More >>
    (SERGEANT BLUFF, IA) Less than 24 hours after strong winds ripped through Sergeant Bluff, heavy duty machinery, firefighters, and volunteers took over.
    More >>
Powered by WorldNow

Siouxland News
100 Gold Circle
Dakota Dunes, SD 57049

Main Phone: 712-277-3554
Main Fax: 712-255-5250
Email: webmaster@siouxlandnews.com

Powered by WorldNow
All content © Copyright 2000 - 2009 WorldNow and Sinclair Communications, LLC. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.